Detalhe da pesquisa
1.
Immune response differs between intralymphatic or subcutaneous administration of GAD-alum in individuals with recent onset type 1 diabetes.
Diabetes Metab Res Rev
; 38(3): e3500, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34611978
2.
GAD-specific T cells are induced by GAD-alum treatment in Type-1 diabetes patients.
Clin Immunol
; 176: 114-121, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28131926
3.
Regulatory T-Cell Phenotyping Using CyTOF.
Methods Mol Biol
; 2559: 231-242, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180636
4.
Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype.
Front Immunol
; 14: 1112570, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36817467
5.
Accurate Enumeration of Apoptotic Cancer Cells Using Flow Cytometry.
Methods Mol Biol
; 2543: 35-44, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087257
6.
Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial).
Acta Diabetol
; 59(5): 687-696, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35098372
7.
Loss of surface antigens is a conserved feature of apoptotic lymphocytes from several mammalian species.
Cell Immunol
; 271(1): 163-72, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21745657
8.
Intralymphatic GAD-alum Injection Modulates B Cell Response and Induces Follicular Helper T Cells and PD-1+ CD8+ T Cells in Patients With Recent-Onset Type 1 Diabetes.
Front Immunol
; 12: 797172, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35095874
9.
Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes Patients.
Front Immunol
; 11: 564921, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33162978
10.
Mass Cytometry Studies of Patients With Autoimmune Endocrine Diseases Reveal Distinct Disease-Specific Alterations in Immune Cell Subsets.
Front Immunol
; 11: 288, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32153591
11.
IFNbeta therapy progressively normalizes the increased ex vivo T lymphocyte apoptosis observed in active patients with multiple sclerosis.
Clin Immunol
; 132(2): 195-202, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19443275
12.
Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients.
Crit Care
; 13(1): R26, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19243622
13.
Mass Cytometry Identifies Distinct Subsets of Regulatory T Cells and Natural Killer Cells Associated With High Risk for Type 1 Diabetes.
Front Immunol
; 10: 982, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31130961
14.
Flow cytometry enumeration of apoptotic cancer cells by apoptotic rate.
Methods Mol Biol
; 414: 23-33, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18175809
15.
Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes.
J Diabetes Res
; 2018: 9391845, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30009185
16.
Flow cytometry enumeration of apoptotic cancer cells by apoptotic rate.
Methods Mol Biol
; 1219: 11-20, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25308258
17.
Increased spontaneous ex vivo apoptosis and subset alterations in peripheral blood T cells from patients with multiple sclerosis.
J Clin Immunol
; 26(2): 101-12, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16758338
18.
Accurate apoptosis measurement requires quantification of loss of expression of surface antigens and cell fragmentation.
Cytometry A
; 69(4): 240-8, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16528734
19.
Apoptotic rate: a new indicator for the quantification of the incidence of apoptosis in cell cultures.
Cytometry
; 48(4): 185-93, 2002 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12210142